Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial

Yana Emmy Hoy-Schulz,Kaniz Jannat,Thomas Roberts,Saira H. Zaidi,Leanne Unicomb,Stephen P. Luby,Julie Parsonnet

Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial

2015

Yana Emmy Hoy-Schulz
Kaniz Jannat
Thomas Roberts
Saira H. Zaidi
Leanne Unicomb
Stephen P. Luby
Julie Parsonnet

Background Probiotics have rarely been studied in young healthy infants from low-income countries. This phase I study investigated the safety and acceptability of two probiotics in Bangladesh.

Keywords:

Alternative medicine
Randomized controlled trial
Traditional medicine
Bifidobacterium
Lactobacillus reuteri
Bifidobacterium longum subspecies infantis
Lactobacillus
Medicine
Pediatrics
phase i study
infant newborn

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations